Dr. Kelly Drahota, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 N 14th St, Rich Hill, MO 64779 Phone: 417-395-4700 Fax: 417-395-2112 |
News Archive
Disruptive behavior was reported in 177 events submitted to the Pennsylvania Patient Safety Authority from May 2007 to October 2009. In many of the events patient care was compromised, according to data released today by the Pennsylvania Patient Safety Authority and published in the June Supplementary Pennsylvania Patient Safety Advisory.
The Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al launches B2Discovery, a new research funding model that brings together the private sector and the biomedical research community to help accelerate the discovery of new anti-cancer therapeutics. Inspired by B2ten, which contributed to the success of several Canadian athletes at the Vancouver Winter Olympics, B2Discovery's mission is to partner entrepreneurs with IRIC's cancer investigators to finance novel and promising research projects not currently funded by public granting agencies.
Findings by scientists from the Max F. Perutz Laboratories (MFPL) of the University of Vienna and the Medical University of Vienna reveal a surprising role for histone deacetylase 1 (HDAC1) - a member of a family of chromatin modifying proteins - in the development of skin tumors.
Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year sole source microscopic urinalysis contract agreement with group purchasing organization Novation. Novation is the leading health care supply contracting company for more than 25,000 members of VHA Inc. and the University HealthSystem Consortium (UHC), two national health care alliances, and 5,500 members of Provista, LLC, representing 28,000 sites.
› Verified 6 days ago